Canada markets open in 3 hours 38 minutes

Akero Therapeutics, Inc. (0K4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
22.60+0.20 (+0.89%)
As of 08:00AM CET. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.56B
Enterprise Value 1.07B
Trailing P/E 8.45
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.13
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.23

Trading Information

Stock Price History

Beta (5Y Monthly) -0.37
52-Week Change 3-40.32%
S&P500 52-Week Change 329.57%
52 Week High 355.00
52 Week Low 310.80
50-Day Moving Average 322.12
200-Day Moving Average 328.53

Share Statistics

Avg Vol (3 month) 314
Avg Vol (10 day) 3N/A
Shares Outstanding 568.95M
Implied Shares Outstanding 669.56M
Float 846.04M
% Held by Insiders 15.92%
% Held by Institutions 194.48%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.07%
Return on Equity (ttm)-35.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -172.84M
Net Income Avi to Common (ttm)-151.76M
Diluted EPS (ttm)-2.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)550.01M
Total Cash Per Share (mrq)9.77
Total Debt (mrq)26.11M
Total Debt/Equity (mrq)4.88%
Current Ratio (mrq)29.27
Book Value Per Share (mrq)9.60

Cash Flow Statement

Operating Cash Flow (ttm)-145.37M
Levered Free Cash Flow (ttm)-93.86M